Form 4: ClearPoint Neuro Executive Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Jeremy L. Stigall, Chief Business Officer of ClearPoint Neuro, sold shares to cover tax obligations related to vesting restricted stock.
Summary
- On June 10, 2024, Jeremy L. Stigall, the Chief Business Officer of ClearPoint Neuro, Inc., disposed of 2,502 shares of common stock.
- The transaction was executed to satisfy tax withholding obligations related to the vesting of restricted stock.
- The shares were sold at a price of $5.74 per share.
- Following the transaction, Stigall beneficially owns 45,192 shares of ClearPoint Neuro, Inc.
Sentiment
Score: 5
Explanation: This is a neutral event. It's a standard transaction for covering tax obligations related to vested stock.
Industry Context
This is a routine transaction related to executive compensation and tax obligations. It is common for executives to sell shares to cover taxes when restricted stock vests.
Stakeholder Impact
- The sale of shares by an executive could have a minor, temporary impact on the stock price, but it's unlikely to be significant given the reason for the sale.
Key Dates
| Date | Description |
|---|---|
| 06/10/2024 | Date of transaction: Jeremy L. Stigall disposed of 2,502 shares of common stock to cover tax obligations. |
| 06/11/2024 | Date of signature: Form 4 signed on June 11, 2024. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.